Patents by Inventor James Michael Smith

James Michael Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SPIROCYCLIC COMPOUNDS
    Publication number: 20240270757
    Abstract: The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: February 16, 2024
    Publication date: August 15, 2024
    Inventors: JAMES MICHAEL SMITH, GRAEME RICHARD ROBB, PIOTR ANTONI RAUBO, BERNARD CHRISTOPHE BARLAAM, IAIN ALEXANDER CUMMING
  • Spirocyclic compounds
    Patent number: 11939344
    Abstract: The specification relates to spirocyclic compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: March 26, 2024
    Assignee: AstraZeneca AB
    Inventor: James Michael Smith
  • SPIROCYCLIC COMPOUNDS
    Publication number: 20230357279
    Abstract: The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: June 15, 2023
    Publication date: November 9, 2023
    Inventors: JAMES MICHAEL SMITH, GRAEME RICHARD ROBB, PIOTR ANTONI RAUBO, BERNARD CHRISTOPHE BARLAAM, IAIN ALEXANDER CUMMING
  • Phenoxyquinazoline compounds and their use in treating cancer
    Patent number: 11053223
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation, pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: July 6, 2021
    Assignee: AstraZeneca AB
    Inventors: Tudor Grecu, Jason Grant Kettle, Martin John Packer, Stuart Eric Pearson, James Michael Smith
  • PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
    Publication number: 20200223828
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation, pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Application
    Filed: April 26, 2018
    Publication date: July 16, 2020
    Inventors: Tudor GRECU, Jason Grant KETTLE, Martin John PACKER, Stuart Eric PEARSON, James Michael SMITH
  • Chemical compounds
    Patent number: 10597405
    Abstract: The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: March 24, 2020
    Assignee: AstraZeneca AB
    Inventors: Jason Grant Kettle, Sharanjeet Bagal, Graeme Richard Robb, James Michael Smith, Frederick Woolf Goldberg, Doyle Joseph Cassar, James Lyman Feron
  • CHEMICAL COMPOUNDS
    Publication number: 20190177338
    Abstract: The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 13, 2019
    Inventors: Jason Grant Kettle, Sharanjeet Bagal, Graeme Richard Robb, James Michael Smith, Frederick Woolf Goldberg, Doyle Joseph Cassar, James Lyman Feron
  • Liquid filter cartridge
    Patent number: 7510088
    Abstract: A water filter cartridge (10) has a two-piece housing (14, 18) internally configured with inlet and outlet openings (12, 16), a diffuser (42), and a plurality of diverter plates (56, 32) to optimize liquid flow and to regulate even flow through a charcoal filter medium (40) located inside of the housing.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: March 31, 2009
    Assignee: Conair Corporation
    Inventors: James Michael Smith, Theodore B. Mulle
  • Liquid filter cartridge
    Publication number: 20080011670
    Abstract: A water filter cartridge (10) has a two-piece housing (14, 18) internally configured with inlet and outlet openings (12, 16), a diffuser (42), and a plurality of diverter plates (56, 32) to optimize liquid flow and to regulate even flow through a charcoal filter medium (40) located inside of the housing.
    Type: Application
    Filed: July 13, 2006
    Publication date: January 17, 2008
    Inventors: James Michael Smith, Theodore B. Mulle